Parkinson's Disease Trial, Recruiting (NCT07348705)

Parkinson's Disease Trial, Recruiting NCT07348705 Sponsor: University of Florida Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07348705 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with idiopathic Parkinson's disease (the most common form, with no known cause) that meets specific recognised diagnostic guidelines
People who have had a Percept deep brain stimulation (DBS) device made by Medtronic surgically implanted to help manage movement symptoms
People who are able to understand and agree to participate in the study by signing a consent form
People who are willing to take part in the study at the time of their first device programming appointment
People aged between 21 and 89 years old

Who may not be able to join:

People who would be unable to follow the study's required procedures and schedule
People who have an atypical form of Parkinsonism (a condition that resembles Parkinson's disease but has a different cause or pattern)
People who have personality or mood-related concerns that the study team believes could interfere with completing the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joshua Wong, MD, University of Florida

Phone: 352-294-5400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07348705

Sponsor: University of Florida

Phase: Not Applicable

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 352-294-5400

More information: https://clinicaltrials.gov/study/NCT07348705

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with idiopathic Parkinson's disease (the most common form, with no known cause) that meets specific recognised diagnostic guidelines
People who have had a Percept deep brain stimulation (DBS) device made by Medtronic surgically implanted to help manage movement symptoms
People who are able to understand and agree to participate in the study by signing a consent form
People who are willing to take part in the study at the time of their first device programming appointment
People aged between 21 and 89 years old

Who may not be able to join:

People who would be unable to follow the study's required procedures and schedule
People who have an atypical form of Parkinsonism (a condition that resembles Parkinson's disease but has a different cause or pattern)
People who have personality or mood-related concerns that the study team believes could interfere with completing the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Florida

Registry

ClinicalTrials.gov

Start date

15 January 2026

Est. completion

15 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Assessment of motor symptoms using the Unified Parkinson's Disease Rating Scale (UPDRS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov